Found 72 matching trials
Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer PHASE2 This is a phase II, single arm, multi-centre study to assess the efficacy o...
Show More Status
Active Not Recruiting
Location
Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum
Learn More & Join Trial
Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer PHASE1 This phase I trial studies the side effects and how well surgery and heated...
Show More Status
Active Not Recruiting
Location
City of Hope Corona
Learn More & Join Trial
Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer PHASE1 This study comprises a Dose Escalation phase followed by a Dose Expansion p...
Show More Location
University of California at Los Angeles
Learn More & Join Trial
Clinical Trial of Chemotherapy, Oregovomab and Nivolumab in Patients With Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin PHASE1 This is an open-label, single-arm, phase I/II, single-center study with dos...
Show More Location
National University Hospital
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer PHASE3 Drugs used in chemotherapy use different ways to stop tumor cells from divi...
Show More Location
Gynecologic Oncology Group
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube Cancer PHASE1 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Learn More & Join Trial
APX005M in Patients With Recurrent Ovarian Cancer PHASE2 The overall objective is to demonstrate preliminary efficacy of APX005M-car...
Show More Learn More & Join Trial
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer PHASE1 This is a Phase 1b open-label, multicenter study, evaluating the safety, to...
Show More Learn More & Join Trial
Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC) PHASE1 This phase I, open label dose escalation study will investigate the additio...
Show More Location
1199.117.003 Boehringer Ingelheim Investigational Site
Learn More & Join Trial
A Study to Investigate Mocertatug Rezetecan With Bevacizumab Compared With Platinum Doublet With Bevacizumab in Participants With Platinum-sensitive Ovarian Cancer (BEHOLD-Ovarian02) PHASE3 This study specifically aims to evaluate how well mocertatug rezetecan (Mo-...
Show More Location
Multiple Locations
Learn More & Join Trial